Simona Bassi

1.2k total citations
13 papers, 625 citations indexed

About

Simona Bassi is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Simona Bassi has authored 13 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 7 papers in Hematology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Simona Bassi's work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Simona Bassi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Simona Bassi collaborates with scholars based in Italy, Switzerland and Brazil. Simona Bassi's co-authors include Giovanni Martinelli, Michele Baccarani, Nicoletta Testoni, Giuseppe Saglio, Daniela Cilloni, Fabrizio Pane, Marilina Amabile, Barbara Izzo, Gianantonio Rosti and Simona Soverini and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Simona Bassi

13 papers receiving 605 citations

Peers

Simona Bassi
HM Kantarjian United States
Angela Volkert United States
K. Adams United Kingdom
B. Anger Germany
Karin E. Summers United Kingdom
Simona Bassi
Citations per year, relative to Simona Bassi Simona Bassi (= 1×) peers Bruno Villemagne

Countries citing papers authored by Simona Bassi

Since Specialization
Citations

This map shows the geographic impact of Simona Bassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Bassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Bassi more than expected).

Fields of papers citing papers by Simona Bassi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Bassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Bassi. The network helps show where Simona Bassi may publish in the future.

Co-authorship network of co-authors of Simona Bassi

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Bassi. A scholar is included among the top collaborators of Simona Bassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Bassi. Simona Bassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bassi, Simona, Ângela Garcia Rossi, Elena Ronda, et al.. (2022). Mixed T cell CHIMERISM in bone marrow at day+30 after allogeneic stem cell transplantation: Correlation with acute GVHD grades III–IV and no impact on relapse and overall survival. European Journal Of Haematology. 109(1). 83–89. 1 indexed citations
2.
Martinelli, Giovanni, Shu-Fang Hsu Schmitz, Thomas Cerny, et al.. (2010). Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98. Journal of Clinical Oncology. 28(29). 4480–4484. 168 indexed citations
3.
Bertazzoni, Paola, Cristina Rabascio, Liliana Calabrese, et al.. (2010). Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients. Leukemia & lymphoma. 51(8). 1485–1493. 9 indexed citations
4.
Taverna, Christian, Simona Bassi, Felicitas Hitz, et al.. (2010). Rituximab Maintenance Treatment for a Maximum of 5 Years In Follicular Lymphoma: Safety Analysis of the Randomized Phase III Trial SAKK 35/03. Blood. 116(21). 1802–1802. 17 indexed citations
5.
Nassi, Luca, Laura Lavinia Travaini, Sara Steffanoni, et al.. (2008). Interim 18f[FDG] Positron Emission Tomography in Patients with Diffuse Large B-Cell Lymphoma. Blood. 112(11). 3607–3607. 4 indexed citations
6.
Bertazzoni, Paola, Cristina Rabascio, Liliana Calabrese, et al.. (2008). Rituximab and 2-Cda Activity in CLL/SLL Patients: An Update of Pharmacogenomic and Clinical Results. Blood. 112(11). 3171–3171. 1 indexed citations
7.
Iacobucci, Ilaria, Giuseppe Saglio, Gianantonio Rosti, et al.. (2006). Achieving a Major Molecular Response at the Time of a Complete Cytogenetic Response (CCgR) Predicts a Better Duration of CCgR in Imatinib-Treated Chronic Myeloid Leukemia Patients. Clinical Cancer Research. 12(10). 3037–3042. 64 indexed citations
9.
Bassi, Simona, Fausto Castagnetti, Marilina Amabile, et al.. (2004). Imatinib in the Treatment of CML Patients ≥ 65 Years Old in Late Chronic Phase: Results of a Phase II Study of the GIMEMA CML Working Party.. Blood. 104(11). 2935–2935. 1 indexed citations
10.
Martinelli, Giovanni, Alberto M. Martelli, Tiziana Grafone, et al.. (2004). A New Abl Kinase Inhibitor (AMN107) Has In Vitro Activity on CML Ph+Blast Cells Resistant to Imatinib.. Blood. 104(11). 4687–4687. 4 indexed citations
11.
Rosti, Gianantonio, Giovanni Martinelli, Simona Bassi, et al.. (2003). Molecular response to imatinib in late chronic-phase chronic myeloid leukemia. Blood. 103(6). 2284–2290. 56 indexed citations
12.
Zinzani, Pier Luigi, Monica Tani, Annalisa Gabriele, et al.. (2003). High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience.. PubMed. 88(5). 522–8. 7 indexed citations
13.
Giannini, Barbara, Vittorio Montefusco, Nicoletta Testoni, et al.. (2000). Real-time quantification of different types of BcrAbl transcript in chronic myeloid leukemia. Blood. 96. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026